- 英文名称
- Alisol A
- 分子式
- C30H50O5
- 分子量
- 490.72
- 中文别名
- 泽泻萜醇A; 泽写醇; (5R,8S,9S,10S,11S,14R)-11-羟基-4,4,8,10,14-五甲基-17-((2R,4S,5R)-4,5,6-三羟基-6-甲基庚-2-基)-1,2,4,5,6,7,8,9,10,11,12,14,15,16-十四氢-3H-环戊[a]菲-3-酮; (8α,9β,11β,14β,20R,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one; (23S,24R)-11b,23,24,25-Tetrahydroxydammar-13(17)-en-3-one; (8α,9β,14β,23S,24R)-11β,23,24,25-Tetrahydroxy-5α-dammar-13(17)-en-3-one; (8α,9β,11β,14β,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one; Dammar-13(17)-en-3-one, 11,23,24,25-tetrahydroxy-, (8α,9β,11β,14β,23S,24R)-; (5R,8S,9S,10S,11S,14R)-11-Hydroxy-4,4,8,10,14-pentamethyl-17-((2R,4S,5R)-4,5,6-trihydroxy-6-methylheptan-2-yl)-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
- 用途
- 泽泻醇A具有降血脂及胆固醇,抗过敏的作用;用于含量测定/鉴定/药理实验等。实验证明,本品与含有1%胆固醇、2%胆酸钠及0.2%氯化胆碱的食物同时喂养雄性大鼠时,十天后测量治疗组和对照组血液中胆固醇含量,发现本品能明显降低血液中胆固醇水平。